IMARC Group's report titled "Image-guided Therapy Systems Market Report by Product (Ultrasound Systems, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET), Endoscopes, Magnetic Resonance Imaging (MRI), X-ray Fluoroscopy, and Others), Application (Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, Oncology Surgery, Gastroenterology, and Others), End Use (Hospitals and Clinics, Ambulatory Surgical Centers, Research and Academic Institutions, and Others), and Region 2024-2032", The global image-guided therapy systems market size reached US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/image-guided-therapy-systems-market/requestsample
Factors Affecting the Growth of the Image-guided Therapy Systems Industry:
- Growing Adoption of Minimally Invasive (MI) Procedures:
The increasing preference for minimally invasive (MI) procedures, which offer numerous benefits, including reduced patient recovery time, lower risk of complications, and shorter hospital stays, is bolstering the market growth. Image-guided therapy systems enable precise navigation and visualization during surgery, allowing surgeons to target specific areas with high accuracy. This technology is becoming integral in complex procedures, such as neurosurgery, cardiovascular interventions, and orthopedic surgeries, where precision is crucial. The growing patient awareness about the advantages of MI procedures, coupled with advancements in imaging technology, is driving the demand for image-guided therapy systems.
- Technological Advancements in Imaging Modalities:
The rapid advancements in imaging modalities, including magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound, are supporting the market growth. These advancements are improving the accuracy, resolution, and real-time imaging capabilities of these systems, making them indispensable in modern medical procedures. Enhanced imaging technologies allow for better visualization of internal structures, enabling surgeons to perform complex procedures with greater confidence and precision. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) in imaging systems is facilitating automated image analysis, improving diagnostic accuracy and surgical planning.
- Increasing Prevalence of Chronic Diseases:
The rising prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, among the masses is impelling the market growth. These conditions often require precise and targeted treatment approaches, which can be effectively achieved through image-guided therapy. Additionally, in oncology, image-guided radiation therapy (IGRT) allows for accurate targeting of tumors while minimizing damage to surrounding healthy tissues. In cardiology, these systems enable precise placement of stents and other devices during interventional procedures. The growing number of cases of chronic diseases is catalyzing the demand for advanced therapeutic solutions like image-guided therapy systems.
Leading Companies Operating in the Global Image-guided Therapy Systems Industry:
- Analogic Corporation
- Brainlab AG
- FUJIFILM Holdings Corporation
- General Electric Company
- Karl Storz SE & Co. KG
- Koninklijke Philips N.V.
- Medtronic plc
- Siemens Healthineers AG
- Stryker Corporation
- Varian Medical Systems Inc.
Image-guided Therapy Systems Market Report Segmentation:
By Product:
- Ultrasound Systems
- Computed Tomography (CT) Scanners
- Positron Emission Tomography (PET)
- Endoscopes
- Magnetic Resonance Imaging (MRI)
- X-ray Fluoroscopy
- Others
Endoscopes represent the largest segment as they enable direct visualization of internal organs and structures without the need for open surgery.
By Application:
- Cardiac Surgery
- Neurosurgery
- Orthopedic Surgery
- Urology
- Oncology Surgery
- Gastroenterology
- Others
Cardiac surgery holds the biggest market share on account of the increasing incidence of cardiovascular diseases among individuals.
By End Use:
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Research and Academic Institutions
- Others
Hospitals and clinics account for the largest market share due to the rising focus on enhanced patient care.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys a leading position in the image-guided therapy systems market, which can be attributed to the presence of highly developed healthcare infrastructure with advanced medical facilities.
Global Image-guided Therapy Systems Market Trends:
The growing employment of AI and ML technologies is enhancing the capabilities of image-guided systems by enabling more accurate and efficient data analysis, improving decision-making during procedures, and automating complex tasks. AI algorithms assist in real-time image processing, assisting clinicians to identify anomalies and assess tissue characteristics with greater precision.
Additionally, the development of hybrid imaging systems that combine different modalities, including positron emission tomography (PET)-CT or MRI-ultrasound, is offering a favorable market outlook. These hybrid systems offer a more comprehensive view of the anatomical and functional aspects of tissues, enabling better treatment planning and execution.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163